Wittkopp competitive analysis

Explore patent oppositions filed by Wittkopp against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition Date
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMAJun 17, 2026
Pharmaceutical Formulation Comprising EzetimibeASSIA CHEMICAL INDUSTRIESJun 3, 2026
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 2, 2026
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 12, 2026
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026
Methods Of Treatment Of Cholestatic DiseasesGENFITJan 29, 2026
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 19, 2025
Solid State Forms Of Ixazomib CitrateASSIA CHEMICAL INDUSTRIESDec 19, 2025

Latest PTAB cases involving Wittkopp

Discover the latest PTAB cases involving Wittkopp, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Wittkopp with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WITTKOPP10 - - -
ASSIA CHEMICAL INDUSTRIES - 14 - -
ASTRAZENECA - 49 - 18
BRISTOL MYERS SQUIBB IRELAND - 42 - -